2021 Weekly Broadcast Archive

 Date  Content
12/27/2021 Weekly Broadcast: NRG-HN009, NRG-GU011
12/20/2021 Weekly Broadcast NRG-GU009, NRG-GY012, NRG-DT001, NRG-LU002, NRG-BR003, NRG-BR004, NRG-BR007, NRG-GI004, and NRG-GI005
12/14/2021 NRG-GY012: Action Letter and Amendment 5
12/13/2021 Weekly Broadcast: NRG-GU011, RTOG 1308, NRG-CC005, RTOG 1308, NRG-BN010, NRG-BN011, NRG-BR004, NRG-BR007, NSABP B-55, NRG-GI005, NRG-GU008
12/10/2021 RFP for Gyn studies
12/9/2021 NRG-CC005/FORTE - Amendment 3 Activation
12/6/2021 Weekly Broadcast: NRG-BN011, NRG-GU007, NRG-GU008, NRG-BN001, NRG-BR007, NSABP B-55, NRG-BR003, NRG-BR004, NRG-GI004, NRG-GI005, NRG-CC005, NRG-CC008, NRG-LU005
11/29/2021 Weekly Broadcast: NRG-LU004, NRG-LU005, NSABP B-55, NRG-CC003, NRG-GU010
11/24/2021 NSABP B-55/Olympia Data Lock
11/22/2021 Weekly Broadcast: NRG-DT001, NRG-LU005, NRG-BN001, NRG-BR007, NRG-BR003, NRG-BR004, NRG-GI004, NRG-GI005, NRG-CC005, NRG-GU010
11/18/2021 NRG-DT001: Cohort A, Permanently Closed to Accrual
11/15/2021 Weekly Broadcast: NRG-GY018,NRG-GY020, NRG-LU002, NRG-HN009, NRG-BN010, NRG-BR004, NRG-CC005, NRG-GU008, NRG-GU007
11/10/2021 NRG-LU002: Notice of Temporary Closure to Accrual
11/9/2021 Pembrolizumab Action Letter - Amendments for NRG-GY018, NRG-GY020, NRG-LU002
11/8/2021 Weekly Broadcast: NRG-GU010, NRG-GU007, NRG-GY021, NRG-BN005, NRG-BR004, NRG-BR007, NRG-CC005, NRG-LU006
11/4/2021 NRG-GU007: Temporary Closure
11/4/2021 FORTE/NRG-CC005 Overview Sessions
11/3/2021 NRG-GU010 Protocol Activation
11/1/2021 Deadline Extended for PSC Applications
11/1/2021 Weekly Broadcast: NRG-BR004, NRG-BR007, NRG-CC005, NRG-GY020, NRG-GY024, NRG-HN001, NRG-LU006
10/28/2021 NRG-HN007: Closure
10/27/2021 NRG-HN009 Protocol Activation
10/25/2021 Weekly Broadcast:NRG-BR007, NRG-CC005, NRG-HN006
10/18/2021 Weekly Broadcast: GOG-0278, NRG-GY009, NRG-HN002, NRG-CC005, NRG-GY004, NRG-GI005

NRG-GY009 Closure and GOG-0278 Closure

10/11/2021 Weekly Broadcast: FORTE (NRG-CC005), GOG-0278, NRG-GY005, NRG-GY009, NRG-GY012,
10/6/2021 FORTE Study NRG-CC005 Activation
10/4/2021 Weekly Broadcast: NRG-CC007CD, GOG-0278, NRG-GY012, NRG-HN001, NRG-LU002
9/30/2021 Olaparib Action Letter - Amendments for NRG-GY004, NRG-GY005, NRG-GY012, NRG-GY021, NRG-GY023
9/28/2021 PSC Call for Applications
9/27/2021 Weekly Broadcast: NRG-GY009, NRG-GI004, GOG-0274/RTOG 1174, NRG-GY012
9/20/2021 Annual Call for Committee Member Applications
9/20/2021 Weekly Broadcast: NRG-BN001, NRG-CC008, NRG-BR007
9/14/2021 NRG-GU007: Reopening of Dose Level 2 (phase I) for 1 additional patient
9/13/2021 Weekly Broadcast: NRG-DT001, NRG-GI005, NRG-GY018, NRG-LU002, NRG-LU005
9/10/2021 NRG-DT001: Cohort A, Dose Level 3 (Expansion Cohort): Temporarily Closed to Accrual
9/8/2021 NRG-HN008: Recruitment Flyer
9/7/2021 Weekly Broadcast: NRG-GY006, NRG-GY024, NRG-BR002, NRG-HN002, NRG-GI005, NRG-BN007
8/30/2021 Weekly Broadcast: NRG-GY005, NRG-BN010, NRG-GI005, NRG-GY018, NRG-GY022
8/27/2021 Dr. Yom appointed H&N Cancer Committee Chair
8/25/2021 NRG-GY022 Recruiting MALE patients
8/23/2021 Weekly Broadcast: GOG-0278, NRG-GY022, NRG-BR004, NRG-BR007, NSABP B-55, NRG-GI005, NRG-GY021, NRG-LU005
8/16/2021 Weekly Broadcast: NRG-GY012, NRG-GI007, NRG-LU002, NRG-BR004, NRG-GU008, NRG-HN004
8/9/2021 Weekly Broadcast: NRG-GY022, NRG-LU002, NRG-BR004, NRG-CC009, NRG-GI005, RTOG 1216, NRG-LU007, NRG-LU005
8/2/2021 Weekly Broadcast: NRG-BR004, RTOG 1216, NRG-HN004, NSABP B-55
7/30/2021 NRG-HN004 Temporary Closure
7/30/2021 NRG-BR004 Amendments 3-4 Activation
7/26/2021 Weekly Broadcast: NRG-GY018, NRG-BN010, NRG-GU009, NRG-HN007, NRG-LU002
7/19/2021 Weekly Broadcast: NRG-HN008
7/12/2021  Weekly Broadcast: NRG-BR004
7/6/2021 Weekly Broadcast: NRG-BN010, NRG-GU008, NRG-GU009, NRG-CC005, NRG-GI004
7/6/2021 NRG-BN010: Protocol Activation
7/1/2021 NRG-GU009 Temporary Closure FAQs
6/29/2021 CCTG CE.7 Shipments to TTDR
6/28/2021 Weekly Broadcast: NRG-GU008, NRG-GU009, NRG-GY020, NRG-GI004, NRG-GY009, RTOG 1216, NRG-LU002, NRG-LU005, NRG-LU007, NRG-BR003, NRG-BR004, NRG-HN001
6/28/2021 Dr. Le appointed NRG Group Chair
6/24/2021 NRG-GU008 and GU009 Temporary Closure
6/24/2021 Atezolizumab Action Letter - Amendments for NRG-GI004, NRG-GY009, NRG-LU002, NRG-LU005, NRG-LU007, RTOG 1216
6/23/2021 NRG-BR004 Notice of Temporary Registration & Accrual Hold
6/21/2021 Weekly Broadcast: NRG-GI005, NRG-HN007
6/21/2021 NRG-LU004 Study Closure
6/18/2021 NRG-BR004 Temporary Registration & Accrual Hold
6/14/2021 Weekly Broadcast: NRG-BR007, NRG-GI004
6/14/2021 NRG-GI005 Reopening (US) & Amendment #1
6/14/2021 NRG-HN007 Temporary Closure to Accrual
6/7/2021 Weekly Broadcast: NRG-BR007, NSABP B-55, NRG-GI004, GOG-0247/RTOG 1174/OUTBACK
6/7/2021 NRG-BR007: Protocol Activation
6/4/2021 NSABP B-55 Amd 7 Activation
6/1/2021 Weekly Broadcast: NRG-GI004, NRG-GY023
5/28/2021 NRG at ASCO 2021 Virtual Meeting
5/27/2021 NRG-GY012 Action Letter
5/24/2021 Weekly Broadcast: NRG-GY006, NRG-GI004, NRG-HN006
5/17/2021 Weekly Broadcast: NRG-GY006, NRG-GI004
5/10/2021 Weekly Broadcast: NRG-GU007, NRG-GY006, NRG-CC003, NSABP B-55, NRG-HN008, NRG-LU005
5/5/2021 NRG-GU007: Temporary Closure to Accrual
5/3/2021 Weekly Broadcast: NRG-GY006, NRG-LU003, NRG-BN007, S1914, CCTG CE.7, NRG-HN007, NRG-GY018, NRG-GY019, NRG-GY020, NRG-LU004
4/26/2021 Weekly Broadcast: NRG-GY023, NRG-GU007, GOG-0225
4/19/2021 Weekly Broadcast: NRG-LU005, NSABP B-55, GOG-0225, NRG-HN007
4/12/2021 NRG-CC007CD Amendment 4
4/12/2021 Weekly Broadcast: GOG-0225,  NRG-HN005
4/5/2021 Weekly Broadcast: NRG-LU003, NRG-GU007, NRG-GY018, NRG-GY20, NRG-LU005
4/1/2021 NRG-LU003 Temporary Closure
3/30/2021 NSABP B-55 Electronic Signatures Follow-up
3/29/2021 Weekly Broadcast:  NRG-BN007, NRG-HN007, NRG-BR003, NRG-BR004, NRG-LU007
3/22/2021 Weekly Broadcast: GOG-0252, NRG-GY011, NRG-GY020
3/16/2021 NSABP B-55 Electronic Signatures Follow-up
3/15/2021 Weekly Broadcast: NRG-GY009, RTOG 1112, NRG-GY006, NRG-DT001, NRG-BN007, NRG-HN005, NRG-HN007, NRG-GU007, NRG-HN004, RTOG 1216, NRG-CC009
3/10/2021 RTOG 1112: Closure and Dear Patient/Dear Investigator Letters
3/8/2021 Weekly Broadcast: NRG-RTOG 1108, NRG-GY018
3/4/2021 RTOG 1008: Closure Notice
3/1/2021 Weekly Broadcast: NRG-CC008, NRG-CC009, RTOG 1112, NSABP B-55, NRG-LU007
2/24/2021 NRG-RTOG 1112: Closure Notice and Dear Patient/Dear Investigator Letters
2/24/2021 NRG-CC009: Protocol Activation
2/23/2021 NRG COVID-19 Vaccine Statement
2/22/2021 Weekly Broadcast: NRG-CC004, NRG-GI002, NRG-RTOG 1216, NRG-BN009
2/17/2021 NSABP B-55/OlympiA Interim Analysis
2/15/2021 Weekly Broadcast: NRG-GY009, NRG-HN004, NRG-BN009, NRG-BR003
2/9/2021 NRG-GY009: Temporary Suspension
2/8/2021 Weekly Broadcast; NRG-GY016, NRG-GY022; NRG-LU004, NRG-BR003, NRG-BR005, NSABP B-55, NRG-GI004, NRG-GI005, NRG-GI007, NRG-GU007, NRG-GU008, NRG-GU009
2/2/2021 NSABP B-55 Electronic Signatures
2/1/2021 Weekly Broadcast: NRG-GI004
1/29/2021 NRG-GI004 Re-Activation
1/25/2021 Weekly Broadcast: NRG-BR004, NRG-CC007CD
1/18/2021 Weekly Broadcast: NRG-GU007
1/11/2021 Weekly Broadcast: GOG-0209, NRG-GI006, NRG-GY018, NRG-HN007, NRG-BN007, NRG-BN009
1/4/2021 Weekly Broadcast: NRG-GY020, NRG-GI005, NRG-BR004, NRG-CC008



Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.